EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between Liver Damage and Disease Progression Markers with Mortality Risk and Mechanical Ventilation in Hospitalized COVID-19 Patients: A Nationwide Retrospective SARSTer Study

Karol Żmudka iD, Jerzy Jaroszewicz iD, Dorota Zarębska-Michaluk iD, Magdalena Rogalska, Piotr Czupryna iD, Marta Rorat iD, Dorota Kozielewicz iD, Jadwiga Maciukajć, Sławomir Kiciak iD, Magdalena Krępa, Ewa Dutkiewicz, Michał Stojko und 5 weitere

Viruses · 2024

DOI: 10.3390/v16101530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Karol Żmudka und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Hepatology, Medical University of Silesia, 40-635 Katowice, Poland. Hauptthemen laut MEDLINE: COVID-19, Biomarkers, Respiration, Artificial, Liver Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Polish Association of Epidemiologists and Infectiologists, Polish Association of Epidemiologists and Infectiologists.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Liver damage is an important component of acute COVID-19, and the advancement of preexisting liver disease is associated with a worse prognosis; (2)

Methods

A nationwide retrospective study including 7444 patients aimed to evaluate levels of selected markers of liver damage and disease advancement and their association with mortality and mechanical ventilation (MV); (3)

Results

Elevation of the following markers in multivariate models were associated with increased odds of mortality: Alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyltransferase (GGT), lactate dehydrogenase (LDH), fibrosis-4 score (FIB-4), AST-to-platelet ratio index (APRI), and decreased levels of platelet count (PLT). Elevated levels of AST, LDH, APRI, FIB-4, and the AST/ALT ratio and decreased levels of PLT were associated with increased odds of MV in multivariate models. The best predictive accuracy against mortality was achieved with FIB-4 with AUC = 0.733 (95% CI, 0.718–0.749) at the optimal cut-off point of 2.764, while against MV was achieved with LDH with AUC = 0.753 (95% CI, 0.727–0.778) at the optimal cut-off point of 449.5 IU/L. (4)

Conclusions

Our study confirms that the advancement of liver damage contributes to a worse prognosis in COVID-19 patients. Markers for liver damage and the advancement of liver disease can provide predictive value in clinical practice among COVID-19 patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19BiomarkersRespiration, ArtificialLiver DiseasesSARS-CoV-2Disease ProgressionHumansRetrospective StudiesMaleFemaleMiddle AgedAgedAspartate AminotransferasesL-Lactate DehydrogenaseAlanine TransaminasePrognosisAdultgamma-GlutamyltransferasePlatelet CountHospitalizationLiverAged, 80 and over

Stichwörter der Autor:innen

COVID-19SARS-CoV-2alanine aminotransferaseartificialaspartate aminotransferaselactate dehydrogenasesliverliver fibrosisliver function testsmortalityrespiration

Substanzen

BiomarkersAspartate AminotransferasesL-Lactate DehydrogenaseAlanine Transaminasegamma-Glutamyltransferase

Autor:innen und Institutionen

  • Department of Infectious Diseases and Hepatology, Medical University of Silesia, 40-635 Katowice, Poland.
  • Department of Infectious Diseases and Allergology, Jan Kochanowski University, 25-317 Kielce, Poland.
  • Department of Infectious Diseases and Hepatology, Medical University of Bialystok, 15-540 Bialystok, Poland.
  • Department of Infectious Diseases and Neuroinfections, Medical University of Bialystok, 15-540 Bialystok, Poland.
  • Department of Social Sciences and Infectious Diseases, Medical Faculty, Wroclaw University of Science and Technology, 50-470 Wroclaw, Poland.
  • Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 85-030 Bydgoszcz, Poland.

ORCID-Profile: Karol Żmudka, Jerzy Jaroszewicz, Dorota Zarębska-Michaluk, Piotr Czupryna, Marta Rorat, Dorota Kozielewicz, Sławomir Kiciak, Aleksandra Spychał, Przemysław Ciechanowski, Regina Podlasin, Robert Flisiak

Förderung

  • the Polish Association of Epidemiologists and Infectiologists
  • Polish Association of Epidemiologists and Infectiologists

Zitieren

APA

Żmudka, K., Jaroszewicz, J., Zarębska-Michaluk, D., Rogalska, M., Czupryna, P., Rorat, M., Kozielewicz, D., Maciukajć, J., Kiciak, S., Krępa, M., Dutkiewicz, E., Stojko, M., Spychał, A., Ciechanowski, P., Bolewska, B., Podlasin, R., & Flisiak, R. (2024). Association between Liver Damage and Disease Progression Markers with Mortality Risk and Mechanical Ventilation in Hospitalized COVID-19 Patients: A Nationwide Retrospective SARSTer Study. Viruses. https://doi.org/10.3390/v16101530

Vancouver

Żmudka K, Jaroszewicz J, Zarębska-Michaluk D, Rogalska M, Czupryna P, Rorat M, et al. Association between Liver Damage and Disease Progression Markers with Mortality Risk and Mechanical Ventilation in Hospitalized COVID-19 Patients: A Nationwide Retrospective SARSTer Study. Viruses. 2024. doi:10.3390/v16101530

BibTeX
@article{mudka2024,
  author = {Żmudka, Karol and Jaroszewicz, Jerzy and Zarębska-Michaluk, Dorota and Rogalska, Magdalena and Czupryna, Piotr and Rorat, Marta and Kozielewicz, Dorota and Maciukajć, Jadwiga and Kiciak, Sławomir and Krępa, Magdalena and Dutkiewicz, Ewa and Stojko, Michał and Spychał, Aleksandra and Ciechanowski, Przemysław and Bolewska, Beata and Podlasin, Regina and Flisiak, Robert},
  title = {Association between Liver Damage and Disease Progression Markers with Mortality Risk and Mechanical Ventilation in Hospitalized COVID-19 Patients: A Nationwide Retrospective SARSTer Study},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16101530}
}
Kostenlos starten →